Takeda Ventures Inc.

Greater London Legal Chronicle. Giugno 12, 2026

Takeda Sells European Antacid Portfolio to DOC Pharma

By Marco Zingaro

Linklaters has advised Takeda. Takeda’s in-house legal team also served the company. Takeda has completed the disposal of its European antacid products to DOC Pharma, marking...

This content is for members only.
Join Now

Already a member? Accedi

Robert W. Johnson Acquires Stake in Aston Martin Aramco Formula One Team

Atomico Leads $100 Million Seed Investment in AI Infrastructure Startup Callosum

Lodge Group Acquired by Interconnect Solutions Group, a Subsidiary of Diploma PLC

Coastline Housing Secures £25 Million Revolving Credit Facility from Lloyds Bank

Housing Plus Group Secures £961 Million Funding for Housing Investment Post-Merger

The FSE Group Appointed Manager of South East Investment Fund to Support SME Growth

Sword Group Acquires Cloud Optimisation Specialist CirrusHQ

Park Property Management Acquires Factoring Business from Indigo Square

BayWa r.e. Sells Three UK Solar Farms to Capital Dynamics

Blue Owl Capital Acquires Strategic Minority Stake in Hollyport Capital

Preservation Capital Partners Closes Oversubscribed PCP Fund III at €877 Million Hard Cap

Quinbrook Infrastructure Partners Closes Renewables Impact Fund II Above Target

Stevens & Bolton Bolsters Corporate Tax Practice With Lateral Hire

Charles Russell Speechlys Announces the Opening of a New Office in Italy

TLT Appoints Madi Dacwy as a Partner In Its Projects, Infrastructure and Construction Team

Takeda Sells European Antacid Portfolio to DOC Pharma